

| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total Revenue | 95.20 | 46.71 | 32.85 | 22.37 |
| Total Expenses | 81.58 | 38.01 | 26.27 | 19.39 |
| Profit Before Tax | 13.61 | 8.70 | 6.58 | 2.98 |
| Profit After Tax | 10.49 | 5.94 | 6.02 | 3.95 |
| Operating Profit After Depreciation | 17.60 | 9.30 | 7.05 | 3.11 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Fixed Assets | 43.92 | 20.90 | 3.16 | 1.43 |
| Total Non Current Assets | 65.63 | 35.10 | 13.36 | 3.17 |
| Total Current Assets | 90.37 | 51.97 | 49.21 | 10.67 |
| Total Assets | 156 | 87.08 | 62.57 | 13.83 |
| Total Shareholder's Fund | 64.46 | 52.90 | 45.63 | 4.78 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Net Cash From Operating Activities | -10.24 | 2.23 | -19 | -0.21 |
| Net Cash Used In Investing Activities | -13.71 | -20.36 | -9.69 | -0.45 |
| Net Cash Used In Financing Activities | 19.76 | 11.01 | 42.28 | 0.80 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Total Revenue | 70.94 | 46.86 | 32.85 | 22.37 | 9.78 |
| Total Expenses | 53.03 | 37.06 | 26.27 | 19.39 | 8.93 |
| Profit Before Tax | 17.91 | 9.80 | 6.57 | 2.98 | 0.85 |
| Profit After Tax | 13.05 | 7.04 | 6.01 | 3.95 | 0.63 |
| Operating Profit After Depreciation | 19.13 | 10.26 | 7.04 | 3.11 | 1.26 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Fixed Assets | 14.80 | 7.62 | 3.11 | 1.43 | 1.18 |
| Total Non Current Assets | 28.65 | 20.26 | 8.64 | 3.19 | 3.70 |
| Total Current Assets | 69.14 | 52.98 | 47.86 | 10.64 | 7.74 |
| Total Assets | 97.79 | 73.24 | 56.50 | 13.82 | 11.44 |
| Total Shareholder's Fund | 65.73 | 52.67 | 45.63 | 4.78 | -0.47 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Net Cash From Operating Activities | -3.49 | 0.90 | -16.60 | -0.19 | 1.48 |
| Net Cash Used In Investing Activities | -7.88 | -11.01 | -5.56 | -0.50 | -0.56 |
| Net Cash Used In Financing Activities | 7.47 | 2.35 | 35.80 | 0.80 | -0.96 |
| Particulars (in ₹ Cr.) | 2026-03 | 2025-12 | 2025-09 | 2025-06 | 2025-03 |
|---|---|---|---|---|---|
| Total Revenue | - | 25.71 | 31.34 | 23.61 | 34.01 |
| Total Expenses | - | 20.62 | 24.48 | 18.44 | 25.48 |
| Profit Before Tax | - | 6.02 | 6.63 | 3.93 | 6.11 |
| Profit After Tax | 6.87 | 4.65 | 5.09 | 2.78 | 6.14 |
| Operating Profit after Depreciation | - | 9.72 | 8.53 | 6.52 | 10.40 |
| Particulars (in ₹ Cr.) | 2026-03 | 2025-12 | 2025-09 | 2025-06 | 2025-03 |
|---|---|---|---|---|---|
| Total Revenue | - | 23.67 | 27.44 | 18.82 | 20.85 |
| Total Expenses | - | 17.39 | 21.06 | 13.89 | 15.28 |
| Profit Before Tax | - | 5.92 | 6.48 | 4.63 | 6.01 |
| Profit After Tax | 6.01 | 4.01 | 4.94 | 3.48 | 4.35 |
| Operating Profit after Depreciation | - | 7.17 | 7.49 | 5.47 | 7.18 |
| Company | Price | Market Cap (in Cr) |
|---|---|---|
| Sun Pharmaceutical Industries Ltd | ₹1,794.30 | ₹4,30,512.67 |
| Divis Laboratories Ltd | ₹6,651.25 | ₹1,76,569.79 |
| Torrent Pharmaceuticals Ltd | ₹4,570 | ₹1,54,669.57 |
| Cipla Ltd | ₹1,383 | ₹1,11,725.01 |
| Zydus Lifesciences Ltd | ₹1,105.65 | ₹1,11,254.26 |
No data available
To 7 May 2026
05 May 2026, 11:28 am
On 5 May 2026
30 Apr 2026, 10:56 am
On 17 January 2026
14 Jan 2026, 10:15 am
Acquires additional 9.04% stake in Trident Mediquip
02 Jan 2026, 10:07 am
On 11 November 2025
05 Nov 2025, 04:22 pm

Get started with us today and
start building your wealth journey
*By clicking, I agree to the T&C and Whatsapp updates.

Get started with us today and
start building your wealth journey
*By clicking, I agree to the T&C and Whatsapp updates.

Congratulations,
Your Digital savings bank account opening journey is complete.